Hillel D. Posen
CIK: 0002109561
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KALA
KALA BIO, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Posen Hillel D.
Posen Hillel D. (SEC CIK 0002109561) files insider reports with the SEC as Director of KALA BIO, Inc. (KALA).
Signal8 holds 1 ownership filing by Posen Hillel D., a Form 3, filed on Feb 9, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Posen Hillel D.'s filings is in ARLINGTON, MA.
Other insiders filing for KALA BIO, Inc. (KALA)
- Purdy Brendan P., Director
- Minkowitz Avraham, Chief Executive Officer
- Colman Yonatan C., Director
- Berger Chaim D., Director
- Lazar David E., Chief Executive Officer
- OXFORD FINANCE LLC, 10% Owner